← All stocks

Atea Pharmaceuticals, Inc.

AVIR No buying or selling

CIK 0001593899 #3209 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Corcoran Andrea

See Remarks

—

823,576

1.03%

$3.44M

+20.0%

Sommadossi Jean-Pierre

President, CEO, and Chairman

—

767,830

0.9573%

$3.20M

+558.8%

BERGER FRANKLIN M

Director

—

536,097

0.6684%

$2.24M

−37.8%

Lucidi Bruno

Director

—

142,350

0.1775%

$593.81K

+71.2%

Hammond Janet MJ

Chief Development Officer

—

127,665

0.1592%

$532.55K

+220.5%

Polsky Bruce

Director

—

124,806

0.1556%

$520.63K

+90.2%

Murphy Polly A.

Director

—

121,745

0.1518%

$507.86K

+115.7%

Horga Maria Arantxa

Chief Medical Officer

—

96,086

0.1198%

$400.82K

+274.4%

DUNCAN BARBARA GAYLE

Director

—

92,350

0.1151%

$385.24K

+178.6%

Adams Jerome M.

Director

—

92,350

0.1151%

$385.24K

+178.6%

Vavricka John

Chief Commercial Officer

—

82,594

0.1030%

$344.54K

+283.9%

Foster Wayne

EVP, Chief Accounting Officer

—

79,329

0.0989%

$330.92K

+280.3%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Corcoran Andrea

11 Mar 2026

See Remarks

Exercised, kept

60,000

$1.24

$74.40K

Sommadossi Jean-Pierre

3 Feb 2026

President, CEO, and Chairman

Exercised, kept

300,000

$1.24

$372.00K

What was left out

Form 4 filings counted 16

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,234,306

History held since 30 Oct 2020